ArticleBritish journal of cancer2021

Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors.

Wei Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.